Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? A single-center phase 2 study

被引:8
|
作者
Rossi, E
Perrone, F
Labonia, V
Landi, G
Nuzzo, F
Amabile, G
Gridelli, C
Di Maio, M
D'Aiuto, G
de Matteis, A
机构
[1] Natl Canc Inst, Div Med Oncol C, I-80131 Naples, Italy
[2] Natl Canc Inst, Clin Trials Unit, I-80131 Naples, Italy
[3] Civil Hosp, Monteforte, Italy
关键词
D O I
10.1159/000070313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:479 / 480
页数:2
相关论文
共 50 条
  • [1] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Donadio, M
    Ardine, M
    Berruti, A
    Ritorto, G
    Fea, E
    Mistrangelo, M
    Coccorullo, Z
    Bergnolo, P
    Comandone, A
    Bertetto, O
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (02) : 147 - 152
  • [2] Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study
    Michela Donadio
    Mara Ardine
    Alfredo Berruti
    Giuliana Ritorto
    Elena Fea
    Marinella Mistrangelo
    Zaira Coccorullo
    Paola Bergnolo
    Alessandro Comandone
    Oscar Bertetto
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 147 - 152
  • [3] Combined gemcitabine and vinorelbine as second-line chemotherapy in advanced breast cancer (ABC).
    Dimota, A
    Rossi, A
    Bilancia, D
    Rosati, G
    Manzione, L
    ANNALS OF ONCOLOGY, 2000, 11 : 41 - 41
  • [4] Gemcitabine as prolonged infusion and vinorelbine as second-line therapy in metastatic breast cancer: results of a phase-II-study.
    Schmid, P
    Heilmann, V
    Schulz, CO
    Dieing, A
    Lehenhauer-Dehm, S
    Flath, B
    Sezer, O
    Kreienberg, R
    Possinger, K
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S206 - S206
  • [5] Vinorelbine plus mitomycin C as second-line treatment of metastatic breast cancer: A two-stage phase 2 study
    De Placido, S
    Lauria, R
    Perrone, F
    Lombardi, AV
    Carlomagno, C
    Varriale, E
    Costanzo, R
    Leo, L
    De Laurentiis, M
    Bianco, AR
    ONCOLOGY, 2000, 58 (01) : 8 - 14
  • [6] The Combination of Gemcitabine and Vinorelbine is an Active Regimen as Second-Line Therapy in Patients with Metastatic Breast Cancer Pretreated with Taxanes and/or Anthracyclines: a Phase I–II Study
    Alessandro Morabito
    Gianfranco Filippelli
    Sergio Palmeri
    Stefano Cascinu
    Francesco Ferraù
    Vittorina Zagonel
    Domenico Gattuso
    Vincenzo Catalano
    Barbara Capaccetti
    Vittorio Franciosi
    Vincenzo Accurso
    Fedele Scinto
    Giampietro Gasparini
    Breast Cancer Research and Treatment, 2003, 78 : 29 - 36
  • [7] Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy
    Wang, Yue-shen
    Tian, Jing
    Han, Yong
    Han, Shu-mei
    Shi, Sheng-bin
    ONCOLOGY RESEARCH, 2016, 24 (02) : 129 - 135
  • [8] Gemcitabine plus paclitaxel and gemcitabine plus docetaxel in first- or second-line metastatic breast cancer: A phase II randomized trial
    Boccia, R. V.
    Vaughn, L.
    Zeigler, H.
    Wang, Y.
    Gill, J.
    Melemed, A.
    Shonukan, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines:: a phase I-II study
    Morabito, A
    Filippelli, G
    Palmeri, S
    Cascinu, S
    Ferraù, F
    Zagonel, V
    Gattuso, D
    Catalano, V
    Capaccetti, B
    Franciosi, V
    Accurso, V
    Scinto, F
    Gasparini, G
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) : 29 - 36
  • [10] Phase II randomized study of gemcitabine plus vinorelbine versus gemcitabine plus mitoxantrone in advanced metastatic breast cancer elderly women: A first-line chemotherapy
    Latorre, A.
    Monticelli, G.
    Giotta, F.
    Calabrese, R.
    Lorusso, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2006, 17 : VII145 - VII146